Ares (NYSE: ARES) insider files to sell 3,921 shares via 10b5-1

Rhea-AI Filing Summary

Ares Management received a Form 144 notice for a planned sale of 3,921 shares of its common stock. The shares are to be sold on the NYSE around 02/04/2026 through Morgan Stanley Smith Barney, with an aggregate market value of 516,003.60.

The seller acquired the 3,921 shares as restricted stock units from the issuer on 01/31/2026. The filing also reports a prior Rule 10b5-1 sale for Sagati Aghili of 1,849 common shares on 01/22/2026, generating gross proceeds of 299,236.80.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	3921	516003.60	216852343	02/04/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/31/2026	Restricted Stock Units	Issuer			3921	01/31/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for NASEEM SAGATI AGHILI 1800 Avenue of the Stars, Suite 1400 Los Angeles CA 90067	Common	01/22/2026	1849	299236.80

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the ARES Form 144 filed for Sagati Aghili disclose?

The Form 144 discloses an intent to sell 3,921 Ares common shares. These shares, acquired as restricted stock units on January 31, 2026, are planned for sale on the NYSE through Morgan Stanley Smith Barney, with an aggregate market value of about 516,003.60.

How many Ares (ARES) shares are planned to be sold under this Form 144?

The notice covers a proposed sale of 3,921 Ares common shares. The filing lists these shares with an aggregate market value of 516,003.60, to be sold on the NYSE, providing transparency about the size of the intended insider-related transaction.

When and how were the ARES shares in the Form 144 acquired?

The 3,921 Ares shares were acquired on January 31, 2026 as restricted stock units. The issuer granted these units, and the same date is listed as both the acquisition and payment date, with the nature of payment marked as N/A in the filing.

What prior Ares (ARES) share sales are reported in the past three months?

The filing reports a prior sale of 1,849 Ares common shares. This transaction occurred on January 22, 2026, under a Rule 10b5-1 plan for Sagati Aghili and generated gross proceeds of 299,236.80, according to the disclosure table.

Which broker is handling the planned Ares (ARES) share sale in this Form 144?

Morgan Stanley Smith Barney LLC is listed as the broker for the sale. The address provided is its Executive Financial Services office at 1 New York Plaza, 8th Floor, New York, NY 10004, handling the intended sale of 3,921 Ares common shares on the NYSE.

On which exchange will the ARES Form 144 shares be sold and when approximately?

The Form 144 indicates the shares are to be sold on the NYSE. The approximate date of sale listed is February 4, 2026, giving investors a time frame for when the 3,921 Ares common shares may enter the market.